Sign In
News Digest /
Ticker: ABBV
Ticker: ABBV
11:16am, Wednesday, Mar 18, 2026
AbbVie and Philip Morris stocks slip amid broader market shifts, while names like GE Vernova, Regencell, and Lumentum post notable gains in a day marked by mixed moves across mega, large, mid, and small caps.
09:11am, Monday, Mar 09, 2026
AbbVie (ABBV) reports encouraging Phase 1 data for ABBV-295, a new amylin analog showing dose-dependent weight loss up to nearly 10% over 12-13 weeks in adults with BMI under 30.
10:02am, Monday, Dec 08, 2025
Ose Immunotherapeutics stock slid over 4% after reshaping its $700M deal with AbbVie, taking on Phase 1 study costs and losing an early milestone payment. AbbVie keeps future rights post-Phase 1.
04:00pm, Monday, Aug 04, 2025
AbbVie Inc. (NYSE: ABBV) - Q2 2025 Financial Overview
In the second quarter of 2025, AbbVie reported mixed results, highlighting both challenges and successes based on their income statement.
Positive Aspects:
Net Revenues: Increased to $15.4 billion, up from $14.5 billion in Q2 2024, representi...
02:06pm, Friday, May 09, 2025
Company Overview: AbbVie Inc. (NYSE: ABBV) continues to position itself as a leader in the biopharmaceutical sector with a diversified portfolio across immunology, neuroscience, oncology, aesthetics, and eye care. Recent strategic moves include the acquisition of Nimble Therapeutics for $288 mill...
06:37am, Tuesday, Apr 22, 2025
Key earnings announcements from April 22-25 include Tesla, SAP, Novartis, Philip Morris, IBM, Google (Class C & A), Procter & Gamble, T-Mobile, and AbbVie. Investors should watch for EPS results and market reactions as Q1 2025 wraps up.
04:13am, Monday, Jan 27, 2025
Upcoming earnings reports this week include SAP, Novo Nordisk, T-Mobile, ServiceNow, Visa, Mastercard, Exxon, AbbVie, and Chevron. Analysts predict key insights from these companies, impacting market trends. Stay tuned for updates!
09:30am, Monday, Sep 16, 2024
These 2 stocks show long-term potential in the healthcare sector. Learn why these stocks are gaining attention and what investors should consider.
06:11am, Monday, Jun 17, 2024
Discover the allure of dividend stocks with insights into AbbVie (NYSE: ABBV) and Visa (NYSE: V). AbbVie thrives on innovation, ensuring resilient payouts with a 3.6% yield, while Visa's 420% dividend surge over a decade underscores its growth potential. Read more!
